Journal of Affective Disorders
Volume 81, Issue 1 , Pages 49-53 , July 2004

Treatment and response in refractory depression: results from a specialist affective disorders service

  • N. Kennedy

      Affiliations

    • Corresponding Author InformationCorresponding author. Box 63, Section of General Psychiatry, Department of Psychological Medicine, Institute of Psychiatry, De Crespigny Park, London SE5 8AF, UK. Tel.: +44-20-7-8480135.
    • ,
  • E.S. Paykel

Received 22 January 2003 ,Revised 7 July 2003 ,Accepted 7 July 2003.

References 

  1. American Psychiatric Association . Practice guidelines for major depressive disorder in adults. Am. J. Psychiatry. 1993;150(Suppl. 4):1–26
  2. Anderson IM, Nutt DJ, Deakin JF. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British association for psychopharmacology guidelines. J. Psychopharmacol. 2000;14:3–20
  3. British Medical Association and Royal Pharmaceutical Society of Great Britain, 2001. British National Formulary. BMA and RPSGB, London.
  4. Georgotas A, McCue RE, Cooper TB, Nagachandran N, Friedhoff A. Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine. Psychiatry Res. 1989;28:1–9
  5. Guy, W., 1976. ECDEU Assessment Manual for Psychopharmacology, DHEW Publication No (ADM) 76-338. US Department of Health, Education and Welfare. National Institute of Mental Health, Rockville, MD.
  6. Guy W. Clinical Global Impressions (CGI) scale. In: Task Force for the Handbook of Psychiatric Measures  editors. Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Association; 2000;p. 100–102
  7. Hirschfeld RM, Montgomery SA, Keller MB, Kasper S, Schatzberg AF, Moller HJ, et al. Social functioning in depression: a review. J. Clin. Psychiatry. 2000;61:268–275
  8. Keller MB, Klerman GL, Lavori PW, Fawcett JA, Coryell W, Endicott J. Treatment received by depressed patients. JAMA. 1982;248:1848–1855
  9. Kienke AS, Rosenbaum JF. Efficacy of venlafaxine in the treatment of severe depression. Depress. Anxiety. 2000;12(Suppl. 1):50–54
  10. Kotin J, Post RM, Goodwin FK. Drug treatment of depressed patients referred for hospitalisation. Am. J. Psychiatry. 1973;130:1139–1141
  11. O'Brien S, McKeon P, O'Regan M. The efficacy and tolerability of combined antidepressant treatment in different depressive subgroups. Br. J. Psychiatry. 1993;162:363–368
  12. Paykel ES, Priest RG. Recognition and management of depression in general practice: consensus statement. Br. Med. J. 1992;305:1198–1202
  13. Price LH, Carpenter LL, Rasmussen LA. Drug combination strategies. In:  Amsterdam JD,  Hornig M,  Nierenberg AA editor. Treatment-Resistant Mood Disorders. Cambridge, UK: Cambridge Univ. Press; 2001;p. 194–222
  14. Prudic J, Haskett RF, Mulsant B, Malone KM, Pettinati HM, Stephens S, et al. Resistance to antidepressant medications and short-term clinical response to ECT. Am. J. Psychiatry. 1996;153:985–992
  15. Razani J, White KL, White J, Simpson G, Sloane RB, Rebal R, et al. The safety and efficacy of combined amitriptyline and tranylcypramine antidepressant treatment. Arch. Gen. Psychiatry. 1983;40:657–661
  16. Schatzberg AF, Cole JO, Cohen BM. Survey of depressed patients who have failed to respond to treatment. In:  Davis JM,  Maas JW editor. The Affective Disorders. Washington, DC: American Psychiatric Press; 1983;p. 73–86
  17. Scott J. Chronic depression. Br. J. Psychiatry. 1988;153:287–297
  18. Simpson GM, Lee JH, Cuculic Z, Kellner R. Two dosages of imipramine in hospitalized endogenous and neurotic depressives. Arch. Gen. Psychiatry. 1976;33:1093–1102
  19. Spitzer RL, Endicott J, Robins E. Research diagnostic criteria: rationale and reliability. Arch. Gen. Psychiatry. 1978;35:773–782
  20. Stimson N, Agrawal N, Lewis G. Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression. Systematic review. Br. J. Psychiatry. 2002;181:284–294
  21. World Health Organization . The ICD-10 Classification of Mental and Behavioural Disorders. Geneva: WHO; 1992;
  22. Young JPR, Lader MH, Hughes WC. Controlled trial of trimipramine, monoamine oxidase inhibitors and combined treatment in depressed outpatients. Br. Med. J. 1979;279:1315–1317
  23. Young WF, Laws ER, Sharbrough FW, Weinshilboum RM. Human monoamine oxidase. Lack of brain and platelet correlation. Arch. Gen. Psychiatry. 1986;43:604–609

PII: S0165-0327(03)00192-7

doi: 10.1016/S0165-0327(03)00192-7

Journal of Affective Disorders
Volume 81, Issue 1 , Pages 49-53 , July 2004

Article Tools